Xue Xingting, Zhou Hongbing, Gao Jiaxing, Li Xinghua, Wang Jia, Bai Wanfu, Bai Yingchun, Fan Liya, Chang Hong, Shi Songli
Department of Pharmacy, Baotou Medical College, Baotou, 014040, China.
Changzhi People's Hospital, The Affiliated Hospital of Changzhi Medical College, Changzhi, Shanxi Province, China.
Heliyon. 2024 Sep 26;10(19):e38339. doi: 10.1016/j.heliyon.2024.e38339. eCollection 2024 Oct 15.
Traditional Chinese medicine (TCM) and dietary compounds have a profound influence on the regulation of gut microbiota (GM) in hepatic fibrosis (HF). Certain substances found in both food and herbs that are edible and medicinal, such as dietary fiber, polyphenols, and polysaccharides, can generate beneficial metabolites like short-chain fatty acids (SCFAs), bile acids (BAs), and tryptophan (Trp). These compounds contribute to regulate the GM, reduce levels of endotoxins in the liver, and alleviate fibrosis and inflammation in the liver. Furthermore, they enhance the composition and functionality of GM, promoting the growth of beneficial bacteria while inhibiting the proliferation of harmful bacteria. These mechanisms mitigate the inflammatory response in the intestines and maintain the integrity of the intestinal barrier. The purpose of this review is to analyze how the GM regulates the pathogenesis of HF, evaluate the regulatory effect of TCM and dietary compounds on the intestinal microflora, with a particular emphasis on modulating flora structure, enhancing gut barrier function, and addressing associated pathogenic factors, thereby provide new insights for the treatment of HF.
Crit Rev Food Sci Nutr. 2018-12-20
Front Endocrinol (Lausanne). 2023
Crit Rev Toxicol. 2024-9
Int Immunopharmacol. 2024-9-30
Microbiome. 2024-2-10
Diabetes Metab J. 2024-3
Signal Transduct Target Ther. 2023-12-6